He L - Search Results

1

Intrasplenic transplantation of IL-18 gene-modified hepatocytes: an effective approach to reverse hepatic fibrosis in schistosomiasis through induction of dominant Th1 response.

Zhang LH, Pan JP, Yao HP, Sun WJ, Xia DJ, Wang QQ, He L, Wang J, Cao X. Zhang LH, et al. Among authors: he l. Gene Ther. 2001 Sep;8(17):1333-42. doi: 10.1038/sj.gt.3301524. Gene Ther. 2001. PMID: 11571570

2

Interleukin-18 gene transfer increases antitumor effects of suicide gene therapy through efficient induction of antitumor immunity.

Ju DW, Yang Y, Tao Q, Song WG, He L, Chen G, Gu S, Ting CC, Cao X. Ju DW, et al. Among authors: he l. Gene Ther. 2000 Oct;7(19):1672-9. doi: 10.1038/sj.gt.3301291. Gene Ther. 2000. PMID: 11083476

3

Intratumoral IL-18 gene transfer improves therapeutic efficacy of antibody-targeted superantigen in established murine melanoma.

Wang Q, Yu H, Ju DW, He L, Pan JP, Xia DJ, Zhang LH, Cao X. Wang Q, et al. Among authors: he l. Gene Ther. 2001 Apr;8(7):542-50. doi: 10.1038/sj.gt.3301428. Gene Ther. 2001. PMID: 11319621

4

Vaccination with IL-18 gene-modified, superantigen-coated tumor cells elicits potent antitumor immune response.

Wang Q, Yu H, Zhang L, Ju D, Pan J, Xia D, He L, Wang J, Cao X. Wang Q, et al. Among authors: he l. J Cancer Res Clin Oncol. 2001 Dec;127(12):718-26. doi: 10.1007/s004320100291. J Cancer Res Clin Oncol. 2001. PMID: 11768611

5

[Enhanced antitumor effects induced by lymphotactin gene-modified dendritic cells after pulsed with tumor antigen peptide].

Zhang W, He L, Cao X. Zhang W, et al. Among authors: he l. Zhonghua Yi Xue Za Zhi. 1999 Mar;79(3):170-3. Zhonghua Yi Xue Za Zhi. 1999. PMID: 11601032 Chinese.

6

Enhanced therapeutic efficacy of tumor RNA-pulsed dendritic cells after genetic modification with lymphotactin.

Zhang W, He L, Yuan Z, Xie Z, Wang J, Hamada H, Cao X. Zhang W, et al. Among authors: he l. Hum Gene Ther. 1999 May 1;10(7):1151-61. doi: 10.1089/10430349950018148. Hum Gene Ther. 1999. PMID: 10340547

7

Involvement of MHC class I molecule and ICAM-1 in the enhancement of adhesion and cytotoxic susceptibility to immune effector cells of tumor cells transfected with the interleukin (IL)-2, IL-4 or IL-6 gene.

Cao X, Chen G, He L, Zhang W, Yu Y, Wang J. Cao X, et al. Among authors: he l. J Cancer Res Clin Oncol. 1997;123(11-12):602-8. doi: 10.1007/s004320050112. J Cancer Res Clin Oncol. 1997. PMID: 9620217

8

Chemoattractive effect on the effector cells of the supernatants from melanoma cells transfected with the interleukin-2 (IL-2), IL-4 or IL-6 gene.

Cao X, Chen G, He L, Zhang W, Yu Y, Ye TX. Cao X, et al. Among authors: he l. J Cancer Res Clin Oncol. 1998;124(2):88-92. doi: 10.1007/s004320050139. J Cancer Res Clin Oncol. 1998. PMID: 9654191

9

Lymphotactin gene-modified bone marrow dendritic cells act as more potent adjuvants for peptide delivery to induce specific antitumor immunity.

Cao X, Zhang W, He L, Xie Z, Ma S, Tao Q, Yu Y, Hamada H, Wang J. Cao X, et al. Among authors: he l. J Immunol. 1998 Dec 1;161(11):6238-44. J Immunol. 1998. PMID: 9834111

10

Interleukin 18 transfection enhances antitumor immunity induced by dendritic cell-tumor cell conjugates.

Ju DW, Tao Q, Lou G, Bai M, He L, Yang Y, Cao X. Ju DW, et al. Among authors: he l. Cancer Res. 2001 May 1;61(9):3735-40. Cancer Res. 2001. PMID: 11325846

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19,337 results

Search Page

Filters